Macrophage (monocyte)-derived mucous secretagougue (MMS) is released into the fluid of the middle ear of patients with otitis media with effusion.
Macrophage (monocyte)-derived secretagogue (MMS) is a low molecular weight peptide released by activated macrophages. This substance can enhance incorporation of carbohydrates into protein and result in the production of glycoproteins. It is believed that increased glycoproteins lead to the increased tenaciousness of mucoid effusions. Sixteen of 28 middle ear effusions demonstrated significant amounts of MMS. It is suggested that MMS is produced by activated macrophages in MEE and may lead to the development of glycoprotein by secretory epithelial cells. This substance may lead to the development of the mucoid effusion in otitis media with effusion in children.
Bernstein
J M
JM
Department of Speech-Language and Audiology, State College of New York, Buffalo.
Goswami
S
S
Marom
Z
Z
D000293:Adolescent; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D004432:Ear, Middle / Q000503:physiopathology*; D006023:Glycoproteins / Q000378:metabolism / Q000502:physiology; D006801:Humans; D007223:Infant; D008875:Middle Aged; D009000:Monocytes / Q000378:metabolism*; D009093:Mucus / Q000502:physiology*; D010034:Otitis Media with Effusion / Q000503:physiopathology*
D006023:Glycoproteins